Early Phase Drug Evaluation in Man

This book is a practical detailed and comprehensive guide for those involved in the conduct of early human studies with new drugs. It covers the pre-clinical information relevant to first human studies including pharmaceutical, metabolic, toxicological and regulatory aspects, as well as the general...

Full description

Bibliographic Details
Other Authors: Linet, Otto I. (Editor), O'Grady, John (Editor)
Format: eBook
Language:English
Published: London Macmillan Education UK 1990, 1990
Edition:1st ed. 1990
Subjects:
Online Access:
Collection: Springer Book Archives -2004 - Collection details see MPG.ReNa
LEADER 01674nmm a2200277 u 4500
001 EB001884949
003 EBX01000000000000001048316
005 00000000000000.0
007 cr|||||||||||||||||||||
008 191115 ||| eng
020 |a 9781349107056 
100 1 |a Linet, Otto I.  |e [editor] 
245 0 0 |a Early Phase Drug Evaluation in Man  |h Elektronische Ressource  |c edited by Otto I Linet, John O'Grady 
250 |a 1st ed. 1990 
260 |a London  |b Macmillan Education UK  |c 1990, 1990 
300 |a X, 737 p  |b online resource 
653 |a Pharmacy 
653 |a Pharmacy 
653 |a Pharmacology 
653 |a Pharmacology/Toxicology 
700 1 |a O'Grady, John  |e [editor] 
041 0 7 |a eng  |2 ISO 639-2 
989 |b SBA  |a Springer Book Archives -2004 
856 4 0 |u https://doi.org/10.1007/978-1-349-10705-6?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 615 
520 |a This book is a practical detailed and comprehensive guide for those involved in the conduct of early human studies with new drugs. It covers the pre-clinical information relevant to first human studies including pharmaceutical, metabolic, toxicological and regulatory aspects, as well as the general considerations relevant to all early human studies. Each major therapeutic area is considered by class of activity of drug. The chapters describe what measurements of drug activity are available in healthy human subjects and in patients, how to make the measurements, their value and their limitations. The contributors are drawn internationally both from the pharmaceutical industry and academia. The book provides a unique practical guide to all concerned with the development of new drugs